Piroxicam Nanostructured Lipid Carrier Drug Delivery System

Abstract

Objective Nanostructured lipid carrier NLC based topical gel of Piroxicam PXM was formulated with the aim of controlled release action and to reduce systemic side effect for the treatment of an arthritic condition. Methods NLCs developed using high pressure homogenization method and optimized using a 32 factorial design with response surface methodology using design expert software. NLCs were characterized for particle size, zeta potential analysis, drug entrapment efficiency, and in vitro drug release studies to select the optimized formulation. The NLCs were suitably gelled and evaluated with respect to homogeneity, pH, viscosity, gel strength, spread ability, rheological characteristics, drug content, in vitro diffusion, and stability study. Safety of the NLC based gel was assessed using primary skin irritation studies, and efficacy was confirmed using carrageen an induced rat paw edema model. Results NLCs formulation comprising 2 of lipid 60 40 and surfactant 1.50 was confirmed as an optimized batch having a particle size 138.2±3.60 nm with polydispersibility index value 0.344±0.034. The zeta potential value indicates good physical stability. Based on the results from the in vitro release study it was shown that the formed gels had the ability to extend release of PXM for 24 h and showing percentage drug release of 90.92 ±1.96 at the end of 24 h. Skin irritation studies revealed that the optimized gel formulation shows no erythema, edema, or ulceration. Conclusion The overall results of the present study clearly indicated promising potentials of NLC based gel for delivering PXM topically over the conventional gel. Dr. G. Jagadish | Dr. Rita Mourya | Dr. Amith Nayak "Piroxicam Nanostructured Lipid Carrier Drug Delivery System" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, URL: https://www.ijtsrd.com/papers/ijtsrd39912.pdf Paper URL: https://www.ijtsrd.com/pharmacy/pharmaceutics/39912/piroxicam-nanostructured-lipid-carrier-drug-delivery-system/dr-g-jagadish

Authors and Affiliations

Dr. G. Jagadish | Dr. Rita Mourya | Dr. Amith Nayak

Keywords

Related Articles

Isolation and Identification of Post-Harvest Fungal Pathogens of Spoilt Grape Fruits

The present investigation was carried out with survey, isolation of the pathogens responsible for post harvest spoilage, their pathogenicity and symptomatology of fungi in order to suggest suitable control for management...

Artificial Intelligence Basics and Terminology

The Artificial intelligence field continues to be plagued by what can only be described as 'bold promises for the future syndrome'. Research in AI has built upon the tools and techniques of many different disciplines, in...

A Study on Work Life Balance

Work life balance is now playing an important role in deciding the job related performance of employees in any industry. Work swelling obligations in the workplace is very difficult for the employees to maintain a fair l...

Financial Health of Food Processing Industry in Tinsukia District of Assam

Food processing industry transforms raw food stuff or semi finished food into a convenient form for the use of end users. This industry is linked with the activities of agriculture, horticulture, plantation, dairy, anima...

Some Considerations about the Socio Political Movements of Young Khivans

This article analyzes the socio political movements of the Young Khiva people in the Khiva Khanate in the early twentieth century.In particular, it is also mentioned about the fact that the revolution in Russia has a pos...

Download PDF file
  • EP ID EP695256
  • DOI -
  • Views 98
  • Downloads 0

How To Cite

Dr. G. Jagadish, Dr. Rita Mourya (2021). Piroxicam Nanostructured Lipid Carrier Drug Delivery System. International Journal of Trend in Scientific Research and Development, 5(3), -. https://europub.co.uk/articles/-A-695256